Novozymes seeks to take appropriate measures to support a precautionary approach to environmental challenges, promote greater environmental responsibility and encourage the development and diffusion of environmentally friendly technologies. Our dedication to addressing and advancing environmental issues is embedded in our Vision, values, and company idea, Touch the World
In support of international environmental conventions such as the United Nations Convention on Biological Diversity
and the principles of the UN Global Compact
, relevant principles are integrated systematically in Novozymes’ management practices
to ensure that global and local initiatives are mutually supportive. In this connection, we have developed specific policies addressing environment and bioethics
. In addition, Novozymes has also developed position papers on a variety of environmental issues related to animal testing
, antibiotic resistance genes in GMMs
, biodiversity, biofuels
, detergent enzymes
, enzymes produced by GMMs
, gene technology
, global warming
, labeling of enzymes
, and responsible purchasing
Based on the above practices, standards, policies, and positions, the relevant boards and departments systematically monitor, report, and follow up on environmental issues at Novozymes on an ongoing basis.
In support of environmental management, development, and transparency, Novozymes reports on the following GRI indicators, EC 2, EN 1, EN 3–8, EN 11–26, EN 28, EN 29, EN 32
, SO 5
, PR 3
, and PR 4
, providing a quantitative counterpart to the environmental dimension.
In 2011, Novozymes met the environmental targets for energy efficiency, CO2 efficiency and impacting climate change by enabling our customers to reduce their CO2 emissions, while the result for water efficiency ended up slightly below the target for 2011.
One of our main initiatives in 2011 was to develop and implement a global environmental management system for our BioBusiness activities. We have also updated our environmental and bioethics and biodiversity standards, which are effective from 2012. The biodiversity standard, outlining the requirements of the United Nations Convention on Biological Diversity, has laid focus on the utilization of genetically modified resources and its implications for our business and strategy. Novozymes has also been able to decouple emissions from growth through continuous optimization and investment in energy-efficient equipment. Our target of meeting the energy needs of the entire operations in Denmark through wind energy by 2012 was met 1 year earlier, as part of an initiative to increase the use of environmentally friendly technology. Through our corporate citizenship activities, we engaged with local communities in all our regions and were able to create awareness of environmental sustainability. Our initiative in Mozambique, CleanStar Mozambique, and participation in the COP17 conference
have helped create awareness and disseminate climate-friendly technology.
Integration of environmental management system in BioBusiness
After undertaking a complete gap analysis of the environmental management setup within BioBusiness activities, we were able to implement the ISO 14001 environmental management system in this young and growing business segment in 2011. This ensures a standard global working procedure to evaluate and update environmental impacts. In addition, it will also provide the necessary framework to set targets and action plans to handle these impacts. As part of efforts to introduce ISO 14001, training programs have been conducted for regional environmental management representatives in all our BioBusiness production facilities around the world. The introduction of ISO 14001 into BioBusiness will complement the environmental management system already working successfully in Enzyme Business.
In anticipation of future constraints and challenges related to the environment, we adopt a precautionary approach and continuously work toward improving our own environmental efficiency performance. As part of our drive to reduce our environmental impacts, we set targets
specifically related to efficiency of water and energy consumption and CO2 emissions. The graph below illustrates our efficiency in 2011, taking 2005 as our baseline.
Reducing environmental impacts together with our customers
Reducing carbon emissions makes good business sense and is a high priority for Novozymes. Our overall carbon footprint comprises around 250,000 tons of CO2
emissions per year from our raw materials and 550,000 tons from our own production, including energy consumption. By way of comparison, our enzyme applications reduced our customers’ CO2
emissions by an estimated 45 million tons in 2011. At Novozymes, we develop product life cycle assessments (LCAs)
based on the ISO 14040 methodology and analyze the impact on the environment at every stage of a product’s life cycle, and we find that the use of enzyme technology generally provides environmental benefits.
Novozymes joins Carbon Disclosure Project elite
Novozymes featured in the Carbon Disclosure Project’s
annual Nordic Carbon Disclosure Leadership Index for the second time in 2011, climbing strongly to 10th place in a comprehensive field of more than 260 listed companies. The CDP assesses the companies’ climate change disclosures, with high scores indicating good internal data management and sound understanding of climate-related risks and opportunities affecting the company. More information about this can be found in the CDP Nordic 260 Report 2011
Novozymes purchases transport services from providers in different countries around the world. Calculating the environmental impact of transport is extremely complex and requires close collaboration with the transport suppliers. Novozymes discloses data on CO2
emissions derived from transport broken down by land, sea, and air. In 2011 we have looked more systematically into the environmental impacts from transportation. Transport data for 2011 include export of products from production sites to the first delivery place where Novozymes pays for the freight, covering more than 90% of Novozymes’ sales, as well as transport between production sites. More information about this can be found under Transport and the environment
on our website and in The Novozymes Report 2011
Development of new guidelines for biomass distribution and change control in 2012
In our effort to promote greater environmental responsibility, we will focus on the continuation of a biomass distribution project started in 2011. Through this, we will develop and implement guidelines that will cover aspects related to biomass that contains GMOs, and procedures and requirements from inactivation to disposal phase, and further standardize compliance across all our facilities. The coming year will also see the development of environmental guidelines related to change control at a production facility, so as to be able to take into consideration and map environmental impacts related to various changes that occur at the production facility.
Focus on supplier chain improvements
After completion of the assessment of the raw materials with the greatest environmental impact in 2011, we are in the process of drawing up plans to improve raw material sourcing and substitute selected raw materials with sustainable alternatives. Apart from this, we are also establishing further engagements with suppliers so as to develop initiatives to reduce environmental impact. More information about this can be found under Engaging with suppliers
. As a strategic project for 2012 anchored in the Sustainability Development Board, Novozymes has allocated resources for the development and implementation of this project going forward.
As another strategic project anchored in the Sustainability Development Board, Novozymes will also continue to further explore aspects related to Green Economy, developing trends, and the role of Novozymes in this discourse. More information regarding our activities related to this can be found at Rio+20 under Engaging and taking action